Skip to main content

Closed

CNTX: Context Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-82.9%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio8.96×

Context Therapeutics Inc.

CNTXNASDAQ·USD·Closed

Context Therapeutics Inc.

CNTXNASDAQ·USD·Closed

$0.60

−1.30%

$0.60

−$0.01 (1.30%)

52W Range

2thpctl

Volume

0.40×avg

Mkt Cap

55.07MUSD

P/E

-1.4TTM

Div Yield

–ann

52W Range

2thpctl

Volume

0.40×avg

Market Cap

55.07MUSD

P/E Ratio

-1.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings